Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | News
Search Refinements

Clinical Trials News

View news from other Pharmaceutical sectors:
46-60 of 4175 results
Boehringer initiates phase 1 trials of Zealand’s analogs for obesity and diabetes
By PBR Staff Writer
Zealand Pharma says that its partner Boehringer Ingelheim has launched phase 1 clinical trials to assess glucagon/GLP-1 agonist and an amylin analog as new treatment options for obesity and diabetes.
Contract Research & Services > Clinical Trials > News
Pfizer-led consortium begins trial of metastatic breast cancer treatment palbociclib
By PBR Staff Writer
Pfizer, along with Alliance Foundation Trials (AFT) and six other international cancer research groups, has commenced a phase 3 clinical study to assess palbociclib (Ibrance) for the treatment of patients with metastatic breast cancer.
Contract Research & Services > Clinical Trials > News
Ovid Therapeutics recruits first patient in phase 1b/2a trial of TAK-935/OV935 in adults with rare epilepsies
Ovid Therapeutics announced it has randomized the first patient in its Phase 1b/2a clinical trial of TAK-935, also known as OV935, in collaboration with Takeda Pharmaceutical Company Limited.
Contract Research & Services > Clinical Trials > News
Novartis, MMV begin patient trial of antimalarial compound in Africa
By PBR Staff Writer
Novartis and Medicines for Malaria Venture (MMV) have started a patient trial of antimalarial compound, KAF156, in Africa.
Contract Research & Services > Clinical Trials > News
US DOD to commence new trial with Pluristem's PLX-R18 cell therapy against ARS
Pluristem Therapeutics stated that a pilot study of its PLX-R18 cell therapy will be initiated by the US Department of Defense’s (DOD) Armed Forces Radiobiology Research Institute (AFRRI), part of the Uniformed Services University of Health Sciences (USU).
Contract Research & Services > Clinical Trials > News
Mateon’s ovarian cancer treatment CA4P shows favorable results in Focus study
By PBR Staff Writer
Mateon Therapeutics’ ovarian cancer treatment CA4P in combination with Roche’s bevacizumab (Avastin) has showed favorable results in the scheduled interim analysis of the ongoing phase 2/3 Focus study.
Contract Research & Services > Clinical Trials > News
Aradigm gets NIH grant for Linhaliq in pulmonary non-tuberculous mycobacteria treatment
The National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH) have awarded a Small Business Initiative Research (SBIR) grant to Aradigm to study the treatment of two pulmonary non-tuberculous mycobacteria (PNTM) infections, Mycobacterium avium and Mycobacterium abscessus, with the company’s inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin.
Contract Research & Services > Clinical Trials > News
FDA lifts clinical hold on study of Multikine for head and neck cancer
By PBR Staff Writer
The US Food and Drug Administration (FDA) has lifted the clinical hold it had imposed on the CEL-SCI and Ergomed co-developed Multikine’s phase 3 head and neck cancer study.
Contract Research & Services > Clinical Trials > News
BMS’ kidney cancer drug met co-primary endpoint in CheckMate trial
By PBR Staff Writer
Bristol-Myers Squibb’s (BMS) kidney cancer drug Opdivo in combination with Yervoy (ipilimumab) has met the co-primary endpoint of objective response rate (ORR) against sunitinib in CheckMate -214 trial.
Contract Research & Services > Clinical Trials > News
Ophthotech’s wet-AMD drug Fovista fails in phase 3 AMD trial
By PBR Staff Writer
Ophthotech’s anti-PDGF therapy Fovista (pegpleranib) for treating wet age-related macular degeneration (AMD) has failed to meet the primary endpoint in a phase 3 trial.
Contract Research & Services > Clinical Trials > News
Heron initiates phase 3 program for HTX-011 in postoperative pain
Heron Therapeutics has reported positive outcome of a recent End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) regarding its investigational agent, HTX-011, to prevent postoperative pain for the first 72 hours post surgery.
Contract Research & Services > Clinical Trials > News
Allegro’s Luminate succeeds in phase 2 diabetic macular edema trial
By PBR Staff Writer
Allegro Ophthalmics' Luminate integrin peptide therapy has passed a phase 2 trial in diabetic macular edema (DME) patients by meeting its primary endpoint when used as a sequential treatment.
Contract Research & Services > Clinical Trials > News
Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment
By PBR Staff Writer
Cancer Research UK has collaborated with Biotecnol to start early phase clinical trials for new immuno-oncology treatment, Tb535H.
Contract Research & Services > Clinical Trials > News
Zynerba’s cannabis-based epilepsy gel fails in phase 2 trial
By PBR Staff Writer
Zynerba Pharmaceuticals has reported that its cannabis-based epilepsy gel ZYN002 (cannabidiol [CBD] gel) has failed to meet the primary point in a phase 2 clinical trial.
Contract Research & Services > Clinical Trials > News
Lilly’s migraine drug Lasmiditan succeeds in second phase 3 trial
By PBR Staff Writer
Eli Lilly's migraine drug Lasmiditan has met its primary endpoint in a second phase 3 trial.
Contract Research & Services > Clinical Trials > News
46-60 of 4175 results